Lenz Therapeutics Inc (LENZ)

SG&A Expense Growth

-12.20%

Quarterly · Period ending:

LENZ logo

LENZ SG&A Expense Growth

Latest reported-12.20%
LENZ Quarterly SG&A Growth (QoQ) (0.00% → -12.20%)
High-resolution chart · PNG

LENZ sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lenz Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-12.1987%
13.4671%
43.8826%
115.0035%
15.3471%
18.382%
44.0868%
-12.3262%
33.4354%
1.7972%
90.5977%
23.319%
1.2658%
53.0394%
-80.9348%
13.2228%
19.1581%
-24.7576%
44.229%
12.5262%
22.1738%
115.287%
24.6217%
67.5115%
617.3554%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.